← Back to Search

Reducing Tobacco Exposures Among African American Women and Children (FRESH Trial)

N/A
Waitlist Available
Led By Pebbles Fagan, PhD, MPH
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 3, 6,12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to reduce the exposure of African American women and children to tobacco smoke in the Arkansas Delta region.

Eligible Conditions
  • Tobacco Use
  • Secondhand Smoke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 3, 6,12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3, 6,12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Comprehensive smokefree policy implementation
Secondary study objectives
Smoking abstinence
Smoking reduction

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral TreatmentExperimental Treatment1 Intervention
Following baseline, the CHWs will deliver three doses of the intervention to the treatment (intervention) group over a 6-month period with follow-up at 12 months for all WCGs. At 1, 3, and 6 months, WCGs will receive motivational interviewing, educational materials and biofeedback based on the child's saliva sample and WCG's carbon monoxide.
Group II: ControlActive Control1 Intervention
WCGs will receive educational materials in the mail at 1, 3, and 6 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment
2013
Completed Phase 2
~10240

Find a Location

Who is running the clinical trial?

Coalition for a Tobacco Free ArkansasUNKNOWN
2 Previous Clinical Trials
438 Total Patients Enrolled
Tri-County Rural Health NetworkUNKNOWN
University of ArkansasLead Sponsor
496 Previous Clinical Trials
150,464 Total Patients Enrolled
Pebbles Fagan, PhD, MPHPrincipal InvestigatorUniversity of Arkansas
2 Previous Clinical Trials
438 Total Patients Enrolled

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT03476837 — N/A
Tobacco Use Research Study Groups: Control, Behavioral Treatment
Tobacco Use Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT03476837 — N/A
Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT03476837 — N/A
~34 spots leftby Dec 2025